GlassScriptPhysician profile
Bryan W Frank
NPI 1861945941
$3,836.76
in general payments reported to CMS, 2019-2025
36 companies · $1,597 in 2025
The $1,597 reported for 2025 was more than what 88% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $168 · 2023: $915 · 2024: $1,157 · 2025: $1,597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,669.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $457.10 | 2022-2025 | |
| Exact Sciences Corporation | $375.94 | 2023-2025 | Cologuard Collection Kit |
| Scilex Pharmaceuticals INC. | $270.64 | 2022-2024 | Ztlido |
| Pfizer INC. | $245.66 | 2023-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $221.21 | 2023-2024 | Relistor |
| Lilly USA, LLC | $210.09 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Tolmar, INC. | $193.91 | 2023-2025 | Jatenzo |
| Novo Nordisk INC | $191.77 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Collegium Pharmaceutical, INC. | $145.82 | 2022-2024 | Belbuca |
| Abbott Laboratories | $140.73 | 2024-2025 | Proclaim, Freestyle Libre 3 |
| Jazz Pharmaceuticals INC. | $124.91 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $115.74 | 2024-2025 | Airsupra, Farxiga |
| Astellas Pharma US INC | $112.49 | 2025 | Veozah |
| Antares Pharma, INC. | $106.47 | 2024-2025 | Xyosted |
| Corcept Therapeutics | $103.25 | 2025 | Korlym |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acella Pharmaceuticals, LLC | $93.12 | 2024-2025 | NP Thyroid 60 |
| Biohaven Pharmaceutical Holding Company LTD. | $79.37 | 2022 | |
| Vivus LLC | $66.61 | 2025 | Qsymia, Pancreaze |
| Depuy Synthes Sales INC. | $59.04 | 2022-2025 | Monovisc, Orthovisc |
| Avadel Cns Pharmaceuticals, LLC | $56.38 | 2025 | Lumryz |
| Aimmune Therapeutics, INC. | $50.65 | 2025 | Zenpep |
| Medtronic, INC. | $48.25 | 2024 | Intellis Adaptivestim |
| Protega Pharmaceutials INC | $38.10 | 2023 | Roxybond |
| Axsome Therapeutics, INC. | $37.32 | 2025 | Sunosi |
| Zimmer Biomet Holdings, INC. | $37.15 | 2025 | Gel-One Cross-Linked Hyaluronate |
| Bayer Healthcare Pharmaceuticals INC. | $36.25 | 2025 | |
| Ibsa Pharma INC. | $31.11 | 2024-2025 | Tirosint, Licart, Flector |
| Grifols USA, LLC | $29.92 | 2024-2025 | Xembify |
| Kowa Pharmaceuticals America, INC. | $29.37 | 2023 | Seglentis |
| Takeda Pharmaceuticals U.S.A., INC. | $28.94 | 2023-2024 | Gammagard, Hyqvia |
| Nalu Medical, INC. | $22.76 | 2024 | Nalu Neurostimulation System |
| Csl Behring | $22.00 | 2024 | Hizentra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.27 | 2025 | Jardiance |
| Boston Scientific Corporation | $13.66 | 2025 | Wavewriter Alpha Prime 16 |
| Halozyme INC | $13.60 | 2023 | |
| Echosens North America, INC. | $11.16 | 2025 | Fibroscan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Frank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.